Riskpilot← Back to searchSign inGet full accessCALMED NUF
NUFActiveOrg 993017043Os Allé 13, 1777 HaldenWholesale of pharmaceutical and medical goods · NACE 4646Est. 20080 employees
Revenue 2024
NOK 866K
+9% vs 2023
EBITDA margin
-13.4%
-10% vs 2023
Equity ratio
86.6%
Financial strength
Net profit 2024
NOK -116K
-10% vs 2023
| Revenue | NOK 866K | +9% |
| EBITDA | NOK -116K | -10% |
| Net profit | NOK -116K | -10% |
| Total assets | NOK 1,3M | -9% |
| Equity | NOK 1,1M | -9% |
| Employees | 0 | — |
Legal name
CALMED NUF
Org number
993017043
Legal form
Norskregistrert Utenlandsk Foretak
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3. september 2008
Share capital
—
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Bedrive import og salg av produkter til helsesektorn og dermed forenlig virksomhet.
Address
Os Allé 13, 1777 Halden
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 891 | 800 | 1 013 | 797 | 866 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 75 | 87 | 95 | −105 | −116 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 75 | 87 | 95 | −105 | −116 |
| Net financials | −97 | 0 | −0 | 0 | 0 |
| Profit before tax | −22 | 87 | 95 | −105 | −116 |
| Tax | −5 | 19 | 21 | −0 | −0 |
| Net profit | −17 | 68 | 74 | −105 | −116 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 313 | 1 439 | 1 466 | 1 451 | 1 320 |
| Equity | 1 223 | 1 290 | 1 364 | 1 259 | 1 144 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 90 | 148 | 102 | 192 | 176 |
| Total debt | 90 | 148 | 102 | 192 | 176 |
EBITDA margin
-13.4%
This company
15.8%
Market median
-185% vs market
20202024
Equity ratio
86.6%
This company
38.2%
Market median
+127% vs market
20202024
Return on equity
-10.1%
This company
18.4%
Market median
-155% vs market
20202024
Net profit margin
-13.3%
This company
8.1%
Market median
-264% vs market
20202024
Asset turnover
0.66×
This company
1.12×
Market median
-41% vs market
20202024
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SC Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2013 | |
| Board of Directors | 2013 | |
| Chairman | 2013 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CALMED NUF also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stefan Claus Priwin | Chief Executive Officer | 0 companies |
| Claudia Michaela Priwin | Board of Directors | 0 companies |
| Claes Joachim Laban Palme | Board of Directors | 0 companies |
| Hasse Sigvard Palme | Chairman | 0 companies |